This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Genecor International, Inc., National Autonomous University of Mexico. Active years: 2005.
Company Filing History:
1 out of 23 
1 out of 41 Years Active: 2005
Title: Noemi Mejia: Innovator in Biosynthetic Production
Introduction
Noemi Mejia is a prominent inventor based in Cuernavaca, Mexico. She has made significant contributions to the field of biosynthetic production, particularly through her innovative approaches to enhancing carbon flow in host cells.
Latest Patents
Noemi holds a patent titled "Application of glucose transport mutants for production of aromatic pathway compounds." This invention describes methods for enhancing carbon flow into a pathway of a host cell to improve the biosynthetic production of compounds. The host cells selected for this process are phenotypically Pts/glucose mutants, which can transport glucose without consuming PEP. This results in the conservation of PEP, allowing it to be redirected into the pathway to enhance the production of desired compounds. The use of Pts/glucose mutants has been shown to be advantageous for the enhanced production of aromatic amino acids. She has 1 patent to her name.
Career Highlights
Throughout her career, Noemi has worked with notable organizations, including the National Autonomous University of Mexico and Genecor International, Inc. Her work has focused on innovative methods that contribute to advancements in biosynthetic production.
Collaborations
Noemi has collaborated with esteemed colleagues such as Fernando Valle and Alan Berry, further enriching her research and contributions to the field.
Conclusion
Noemi Mejia is a trailblazer in the realm of biosynthetic production, with her innovative patent and collaborations highlighting her impact in the scientific community. Her work continues to pave the way for advancements in the production of valuable compounds.